Ruby-Fill
Payments companies reported to CMS as associated with Ruby-Fill. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ruby-Fill, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ruby-Fill
These are the largest totals companies reported as associated with Ruby-Fill. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mouaz Al-Mallah | Detroit, MI | Cardiovascular Disease | $8,600.00 |
| Howard Lewin | Los Angeles, CA | Nuclear Cardiology | $5,100.00 |
| Navid Homayouni | Washington, DC | Nuclear Radiology | $189.80 |
| Carlos Garcia | Washington, DC | Nuclear Medicine | $189.80 |
| Edward Obedian | Oyster Bay, NY | Radiation Oncology | $147.92 |
Prescribed Ruby-Fill?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.